Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl Cysteine for Refractory Generalized Epilepsy in Children With Autism
NCT02054949Withdrawn
- Sponsor
- Nationwide Children's Hospital
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetylcysteine in epilepsy and irritability, sponsored by Nationwide Children's Hospital. Primary endpoint: Recruitment rate at 1 year. Planned start Apr 2013; status: withdrawn.
02
Drugs
acetylcysteine
03
Conditions
epilepsyirritability
Beyond the preview
Go deeper on NCT02054949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054949.